# A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

> **NCT04214028** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 50 (actual)

## Conditions studied

- Hepatitis C Virus (HCV)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04214028
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-26
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04214028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04214028, "A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04214028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*